Personal tools

Coexpression cluster:C3073: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0051262!protein tetramerization!0.0255556082703558!81846$GO:0046839!phospholipid dephosphorylation!0.0255556082703558!81846$GO:0019902!phosphatase binding!0.0255556082703558!81846$GO:0000119!mediator complex!0.0255556082703558!23389$GO:0042552!myelination!0.0255556082703558!81846$GO:0007272!ensheathment of neurons!0.0255556082703558!81846$GO:0008366!axon ensheathment!0.0255556082703558!81846$GO:0001508!regulation of action potential!0.0275084560595357!81846$GO:0030258!lipid modification!0.0275084560595357!81846$GO:0004437!inositol or phosphatidylinositol phosphatase activity!0.0275084560595357!81846$GO:0051259!protein oligomerization!0.0275084560595357!81846$GO:0005774!vacuolar membrane!0.0275084560595357!81846$GO:0044437!vacuolar part!0.0275084560595357!81846$GO:0019208!phosphatase regulator activity!0.0327190157182835!81846$GO:0016591!DNA-directed RNA polymerase II, holoenzyme!0.0428065030946804!23389
|gostat_on_coexpression_clusters=GO:0051262!protein tetramerization!0.0255556082703558!81846$GO:0046839!phospholipid dephosphorylation!0.0255556082703558!81846$GO:0019902!phosphatase binding!0.0255556082703558!81846$GO:0000119!mediator complex!0.0255556082703558!23389$GO:0042552!myelination!0.0255556082703558!81846$GO:0007272!ensheathment of neurons!0.0255556082703558!81846$GO:0008366!axon ensheathment!0.0255556082703558!81846$GO:0001508!regulation of action potential!0.0275084560595357!81846$GO:0030258!lipid modification!0.0275084560595357!81846$GO:0004437!inositol or phosphatidylinositol phosphatase activity!0.0275084560595357!81846$GO:0051259!protein oligomerization!0.0275084560595357!81846$GO:0005774!vacuolar membrane!0.0275084560595357!81846$GO:0044437!vacuolar part!0.0275084560595357!81846$GO:0019208!phosphatase regulator activity!0.0327190157182835!81846$GO:0016591!DNA-directed RNA polymerase II, holoenzyme!0.0428065030946804!23389
|id=C3073
|id=C3073
|ontology_enrichment_celltype=CL:0002057!9.69e-22!42;CL:0000860!4.01e-19!45;CL:0000766!1.62e-16!76;CL:0002009!6.63e-15!65;CL:0002194!3.89e-14!63;CL:0000576!3.89e-14!63;CL:0000040!3.89e-14!63;CL:0000559!3.89e-14!63;CL:0000557!7.87e-14!71;CL:0000839!1.74e-11!70;CL:0000763!9.59e-07!112;CL:0000049!9.59e-07!112
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0007023!5.01e-29!115;UBERON:0002390!1.07e-13!102;UBERON:0003061!1.07e-13!102;UBERON:0001049!1.13e-13!57;UBERON:0005068!1.13e-13!57;UBERON:0006241!1.13e-13!57;UBERON:0007135!1.13e-13!57;UBERON:0002616!3.79e-13!59;UBERON:0001017!1.63e-12!82;UBERON:0000955!1.73e-12!69;UBERON:0006238!1.73e-12!69;UBERON:0002193!3.95e-12!112;UBERON:0000062!4.62e-12!511;UBERON:0003080!6.74e-12!42;UBERON:0000073!8.83e-12!94;UBERON:0001016!8.83e-12!94;UBERON:0002371!1.21e-11!80;UBERON:0001474!1.55e-11!86;UBERON:0004765!1.85e-11!101;UBERON:0001434!1.85e-11!101;UBERON:0005743!1.92e-11!86;UBERON:0002780!2.24e-11!41;UBERON:0001890!2.24e-11!41;UBERON:0006240!2.24e-11!41;UBERON:0001893!1.89e-09!34;UBERON:0000468!2.29e-09!659;UBERON:0002791!3.55e-09!33;UBERON:0002020!3.79e-09!34;UBERON:0003528!3.79e-09!34;UBERON:0000153!4.81e-09!129;UBERON:0007811!4.81e-09!129;UBERON:0000467!5.74e-09!625;UBERON:0000480!7.71e-09!626;UBERON:0001869!7.72e-09!32;UBERON:0000033!1.03e-08!123;UBERON:0003075!1.26e-08!86;UBERON:0007284!1.26e-08!86;UBERON:0000924!1.32e-08!173;UBERON:0006601!1.32e-08!173;UBERON:0002346!1.43e-08!90;UBERON:0004121!1.47e-08!169;UBERON:0002405!2.30e-07!115;UBERON:0000956!5.92e-07!25;UBERON:0000203!5.92e-07!25;UBERON:0002619!7.41e-07!22
}}
}}

Revision as of 14:32, 21 May 2012


Full id: C3073_Eosinophils_Neutrophils_granulocyte_cerebellum_CD14_parietal_vagina



Phase1 CAGE Peaks

Hg19::chr11:10315741..10315773,-p1@SBF2
Hg19::chr12:116715460..116715476,-p4@MED13L
Hg19::chr12:116715483..116715524,-p1@MED13L


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0051262protein tetramerization0.0255556082703558
GO:0046839phospholipid dephosphorylation0.0255556082703558
GO:0019902phosphatase binding0.0255556082703558
GO:0000119mediator complex0.0255556082703558
GO:0042552myelination0.0255556082703558
GO:0007272ensheathment of neurons0.0255556082703558
GO:0008366axon ensheathment0.0255556082703558
GO:0001508regulation of action potential0.0275084560595357
GO:0030258lipid modification0.0275084560595357
GO:0004437inositol or phosphatidylinositol phosphatase activity0.0275084560595357
GO:0051259protein oligomerization0.0275084560595357
GO:0005774vacuolar membrane0.0275084560595357
GO:0044437vacuolar part0.0275084560595357
GO:0019208phosphatase regulator activity0.0327190157182835
GO:0016591DNA-directed RNA polymerase II, holoenzyme0.0428065030946804



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
adult organism5.01e-29115
hematopoietic system1.07e-13102
blood island1.07e-13102
neural tube1.13e-1357
neural rod1.13e-1357
future spinal cord1.13e-1357
neural keel1.13e-1357
regional part of brain3.79e-1359
central nervous system1.63e-1282
brain1.73e-1269
future brain1.73e-1269
hemolymphoid system3.95e-12112
organ4.62e-12511
anterior neural tube6.74e-1242
regional part of nervous system8.83e-1294
nervous system8.83e-1294
bone marrow1.21e-1180
bone element1.55e-1186
skeletal element1.85e-11101
skeletal system1.85e-11101
regional part of forebrain2.24e-1141
forebrain2.24e-1141
future forebrain2.24e-1141
telencephalon1.89e-0934
multi-cellular organism2.29e-09659
regional part of telencephalon3.55e-0933
gray matter3.79e-0934
brain grey matter3.79e-0934
anterior region of body4.81e-09129
craniocervical region4.81e-09129
anatomical system5.74e-09625
anatomical group7.71e-09626
cerebral hemisphere7.72e-0932
head1.03e-08123
neural plate1.26e-0886
presumptive neural plate1.26e-0886
ectoderm1.32e-08173
presumptive ectoderm1.32e-08173
neurectoderm1.43e-0890
ectoderm-derived structure1.47e-08169
immune system2.30e-07115
cerebral cortex5.92e-0725
pallium5.92e-0725
regional part of cerebral cortex7.41e-0722


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.